CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Amerisource Health Services LLC recalls Sucralfate Tablets

Read the official FDA notice

Published
3 Sept 2025
Units affected
26,992 blister packs
Agency
FDA
Country
United States

The hazard

CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217 NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]

Brand / company
Amerisource Health Services LLC
Codes / lots
Lot 1015038, Exp Date 07/31/2025, Lot 1015898, Exp Date 09/30/2025; Lot 1016873, Exp Date 10/31/2025 and Lot 1023398, Exp Date 07/31/2026.
Distribution
Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 3 Sept 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.